-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FbVNrlpdXSLMBIhS6cqbagPIRQgZo9l6TCiEPHoppS3KvRmSYWScfhxXJRYhztqq CCLh281GhuU2e07V/jkmuQ== 0000903423-06-001089.txt : 20060929 0000903423-06-001089.hdr.sgml : 20060929 20060929180340 ACCESSION NUMBER: 0000903423-06-001089 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060920 FILED AS OF DATE: 20060929 DATE AS OF CHANGE: 20060929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Connor Daniel CENTRAL INDEX KEY: 0001376847 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19612 FILM NUMBER: 061118396 BUSINESS ADDRESS: BUSINESS PHONE: (212) 645-1405 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMCLONE SYSTEMS INC CENTRAL INDEX KEY: 0000765258 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042834797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 VARICK STREET - 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-638-5078 MAIL ADDRESS: STREET 1: 180 VARICK STREET - 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: IMCLONE SYSTEMS INC/DE DATE OF NAME CHANGE: 19940211 3 1 oconnor-f3b_0929ex.xml X0202 3 2006-09-20 0 0000765258 IMCLONE SYSTEMS INC IMCL 0001376847 O'Connor Daniel 180 VARICK STREET NEW YORK NY 10014 0 1 0 0 VP, INTERIM GEN. COUNSEL, SEC. STOCK OPTION (RIGHT TO BUY) 53.50 2005-12-16 2014-08-10 COMMON STOCK 625 D PERFORMANCE RIGHTS 32.99 2007-12-31 2007-12-31 COMMON STOCK 48147 D PERFORMANCE RIGHTS 32.99 2008-12-31 2008-12-31 COMMON STOCK 48147 D Cash bonuses under the plan are payable following the end of the performance period, provided that the reporting person remains continuously employed by the Company through that date. Special rules apply in the event of a change in control during the performance period, and in the event the reporting person's employment terminates during the performance period due to death or disability. On 1/18/06, the reporting person received a target cash award opportunity under the ImClone 2006-2008 Retention Plan for the two performance periods commencing on 1/1/06 and ending on, respectively, 12/31/07 and 08. The amount of award received will be calculated at the end of the performance period by comparing the Company's share price at the beginning of the performance period with the Company's share price at the end of the performance period based on a 30-day average. The cash bonus will generally be calculated by adjusting the target award opportunity between 100% and 150% based on any Company share price increase. No bonus will be payable in respect of the performance period if the Company's share price at the conclusion of the performance period is less than the share price at the beginning of the performance period. The number reported herein is a cash amount calculated based on the 100% target. If based on the 150% target, this amount would equal $72,220.50. /s/ Daniel J. O'Connor 2006-09-29 -----END PRIVACY-ENHANCED MESSAGE-----